UK markets closed
  • NIKKEI 225

    27,999.96
    -249.28 (-0.88%)
     
  • HANG SENG

    20,003.44
    -42.33 (-0.21%)
     
  • CRUDE OIL

    90.00
    -0.76 (-0.84%)
     
  • GOLD FUTURES

    1,812.70
    +7.50 (+0.42%)
     
  • DOW

    32,796.65
    -35.89 (-0.11%)
     
  • BTC-GBP

    19,106.90
    -814.13 (-4.09%)
     
  • CMC Crypto 200

    535.98
    -21.37 (-3.83%)
     
  • ^IXIC

    12,462.50
    -181.96 (-1.44%)
     
  • ^FTAS

    4,129.39
    -3.43 (-0.08%)
     

Novartis CEO says no decision has been taken on Sandoz

  • Oops!
    Something went wrong.
    Please try again later.
Swiss drugmaker Novartis' logo is seen in Stein
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ZURICH (Reuters) - Novartis has not decided what to do with its Sandoz generics unit after announcing a strategic review of the business last year, its chief executive said on Monday.

"No decision has been taken on Sandoz, we continue to evaluate the options," Vas Narasimhan said at the J.P. Morgan Healthcare conference. He also said the Swiss drugmaker continued to look for value-creating bolt-on acquisitions.

(Reporting by Silke Koltrowitz; Editing by Michael Shields)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting